Throughout 2025, the team at Angioedema News brought readers the latest updates on research, treatments, clinical trials, and real-world…
Articles by Michela Luciano, PhD
Daily treatment with Orladeyo (berotralstat) oral granules led to early and sustained reductions in swelling attack rates in young…
Most people with hereditary angioedema (HAE) who received a single, 50 mg dose of lonvoguran ziclumeran, also called lonvo-z…
A young man in Greece developed acquired angioedema, one of the rarest forms of angioedema, as a complication…
People with type 2 diabetes who use DPP4 inhibitors to manage their disease do not seem to have a higher…
Orladeyo (berotralstat)Â is now approved for reimbursement in the Netherlands following a recommendation from healthcare government agency Zorginstituut Nederland.